English
简体中文
Total: £ 56.28
Published Date: 2025-11-06 | Pages: 107 | Tables: 102 | Medical Care
The global market for Hyperhidrosis Treatment was estimated to be worth US$ 1465 million in 2024 and is forecast to a readjusted size of US$ 2115 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
In some people, the body’s mechanism for cooling itself is overactive — so overactive that they may sweat four or five times more than is necessary, or normal. When sweating is this extreme it can be embarrassing, uncomfortable, anxiety-inducing, dangerous, and disabling. It often disrupts all aspects of a person"s life, from career choices and recreational activities to relationships, emotional well-being, and self-confidence. This kind of excessive sweating is a serious medical condition. It"s called hyperhidrosis and it afflicts millions of people around the world (nearly 5% of the world"s population). But, due to lack of awareness among sufferers and lack of education among medical professionals, most people are never diagnosed or relieved of their symptoms.
Global top 5 players of hyperhidrosis treatment include Allergan (AbbVie), GlaxoSmithKline, Cynosure, Journey Medical Corporation and miraDry. As the largest player, Allergan (AbbVie) makes up over a quarter.
North America ranks first in terms of market size by region, making up around 35%, followed by Europe and Asia-Pacific.
Based on the product type, the hyperhidrosis treatment is primarily split into medications, surgical treatments and physiotherapy, etc. Among them, medical is the largest segment, with a share over 45%.
Hyperhidrosis treatment is mainly used for primary focal hyperhidrosis and secondary generalized hyperhidrosis, in which the former one dominates with a share over 60%.
This report aims to provide a comprehensive presentation of the global market for Hyperhidrosis Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Hyperhidrosis Treatment by region & country, by Type, and by Application.
The Hyperhidrosis Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hyperhidrosis Treatment.
Market Segmentation
By Company
Allergan (AbbVie)
GlaxoSmithKline
Cynosure
Journey Medical Corporation
miraDry
Alma Lasers
Carpe
Duradry
Merz Ultherapy
Fotona
BTXA
Seaford Pharmaceuticals
Robugen GmbH
Segment by Type
Medications
Surgical Treatments
Physiotherapy
Segment by Application
Primary Focal Hyperhidrosis
Secondary Generalized Hyperhidrosis
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Hyperhidrosis Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Hyperhidrosis Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Hyperhidrosis Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Hyperhidrosis Treatment Product Introduction
1.2 Global Hyperhidrosis Treatment Market Size Forecast (2020-2031)
1.3 Hyperhidrosis Treatment Market Trends & Drivers
1.3.1 Hyperhidrosis Treatment Industry Trends
1.3.2 Hyperhidrosis Treatment Market Drivers & Opportunity
1.3.3 Hyperhidrosis Treatment Market Challenges
1.3.4 Hyperhidrosis Treatment Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Hyperhidrosis Treatment Players Revenue Ranking (2024)
2.2 Global Hyperhidrosis Treatment Revenue by Company (2020-2025)
2.3 Key Companies Hyperhidrosis Treatment Manufacturing Base Distribution and Headquarters
2.4 Key Companies Hyperhidrosis Treatment Product Offered
2.5 Key Companies Time to Begin Mass Production of Hyperhidrosis Treatment
2.6 Hyperhidrosis Treatment Market Competitive Analysis
2.6.1 Hyperhidrosis Treatment Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Hyperhidrosis Treatment Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hyperhidrosis Treatment as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Medications
3.1.2 Surgical Treatments
3.1.3 Physiotherapy
3.2 Global Hyperhidrosis Treatment Sales Value by Type
3.2.1 Global Hyperhidrosis Treatment Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Hyperhidrosis Treatment Sales Value, by Type (2020-2031)
3.2.3 Global Hyperhidrosis Treatment Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Primary Focal Hyperhidrosis
4.1.2 Secondary Generalized Hyperhidrosis
4.2 Global Hyperhidrosis Treatment Sales Value by Application
4.2.1 Global Hyperhidrosis Treatment Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Hyperhidrosis Treatment Sales Value, by Application (2020-2031)
4.2.3 Global Hyperhidrosis Treatment Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Hyperhidrosis Treatment Sales Value by Region
5.1.1 Global Hyperhidrosis Treatment Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Hyperhidrosis Treatment Sales Value by Region (2020-2025)
5.1.3 Global Hyperhidrosis Treatment Sales Value by Region (2026-2031)
5.1.4 Global Hyperhidrosis Treatment Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Hyperhidrosis Treatment Sales Value, 2020-2031
5.2.2 North America Hyperhidrosis Treatment Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Hyperhidrosis Treatment Sales Value, 2020-2031
5.3.2 Europe Hyperhidrosis Treatment Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Hyperhidrosis Treatment Sales Value, 2020-2031
5.4.2 Asia Pacific Hyperhidrosis Treatment Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Hyperhidrosis Treatment Sales Value, 2020-2031
5.5.2 South America Hyperhidrosis Treatment Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Hyperhidrosis Treatment Sales Value, 2020-2031
5.6.2 Middle East & Africa Hyperhidrosis Treatment Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Hyperhidrosis Treatment Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Hyperhidrosis Treatment Sales Value, 2020-2031
6.3 United States
6.3.1 United States Hyperhidrosis Treatment Sales Value, 2020-2031
6.3.2 United States Hyperhidrosis Treatment Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Hyperhidrosis Treatment Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Hyperhidrosis Treatment Sales Value, 2020-2031
6.4.2 Europe Hyperhidrosis Treatment Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Hyperhidrosis Treatment Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Hyperhidrosis Treatment Sales Value, 2020-2031
6.5.2 China Hyperhidrosis Treatment Sales Value by Type (%), 2024 VS 2031
6.5.3 China Hyperhidrosis Treatment Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Hyperhidrosis Treatment Sales Value, 2020-2031
6.6.2 Japan Hyperhidrosis Treatment Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Hyperhidrosis Treatment Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Hyperhidrosis Treatment Sales Value, 2020-2031
6.7.2 South Korea Hyperhidrosis Treatment Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Hyperhidrosis Treatment Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Hyperhidrosis Treatment Sales Value, 2020-2031
6.8.2 Southeast Asia Hyperhidrosis Treatment Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Hyperhidrosis Treatment Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Hyperhidrosis Treatment Sales Value, 2020-2031
6.9.2 India Hyperhidrosis Treatment Sales Value by Type (%), 2024 VS 2031
6.9.3 India Hyperhidrosis Treatment Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Allergan (AbbVie)
7.1.1 Allergan (AbbVie) Profile
7.1.2 Allergan (AbbVie) Main Business
7.1.3 Allergan (AbbVie) Hyperhidrosis Treatment Products, Services and Solutions
7.1.4 Allergan (AbbVie) Hyperhidrosis Treatment Revenue (US$ Million) & (2020-2025)
7.1.5 Allergan (AbbVie) Recent Developments
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Profile
7.2.2 GlaxoSmithKline Main Business
7.2.3 GlaxoSmithKline Hyperhidrosis Treatment Products, Services and Solutions
7.2.4 GlaxoSmithKline Hyperhidrosis Treatment Revenue (US$ Million) & (2020-2025)
7.2.5 GlaxoSmithKline Recent Developments
7.3 Cynosure
7.3.1 Cynosure Profile
7.3.2 Cynosure Main Business
7.3.3 Cynosure Hyperhidrosis Treatment Products, Services and Solutions
7.3.4 Cynosure Hyperhidrosis Treatment Revenue (US$ Million) & (2020-2025)
7.3.5 Cynosure Recent Developments
7.4 Journey Medical Corporation
7.4.1 Journey Medical Corporation Profile
7.4.2 Journey Medical Corporation Main Business
7.4.3 Journey Medical Corporation Hyperhidrosis Treatment Products, Services and Solutions
7.4.4 Journey Medical Corporation Hyperhidrosis Treatment Revenue (US$ Million) & (2020-2025)
7.4.5 Journey Medical Corporation Recent Developments
7.5 miraDry
7.5.1 miraDry Profile
7.5.2 miraDry Main Business
7.5.3 miraDry Hyperhidrosis Treatment Products, Services and Solutions
7.5.4 miraDry Hyperhidrosis Treatment Revenue (US$ Million) & (2020-2025)
7.5.5 miraDry Recent Developments
7.6 Alma Lasers
7.6.1 Alma Lasers Profile
7.6.2 Alma Lasers Main Business
7.6.3 Alma Lasers Hyperhidrosis Treatment Products, Services and Solutions
7.6.4 Alma Lasers Hyperhidrosis Treatment Revenue (US$ Million) & (2020-2025)
7.6.5 Alma Lasers Recent Developments
7.7 Carpe
7.7.1 Carpe Profile
7.7.2 Carpe Main Business
7.7.3 Carpe Hyperhidrosis Treatment Products, Services and Solutions
7.7.4 Carpe Hyperhidrosis Treatment Revenue (US$ Million) & (2020-2025)
7.7.5 Carpe Recent Developments
7.8 Duradry
7.8.1 Duradry Profile
7.8.2 Duradry Main Business
7.8.3 Duradry Hyperhidrosis Treatment Products, Services and Solutions
7.8.4 Duradry Hyperhidrosis Treatment Revenue (US$ Million) & (2020-2025)
7.8.5 Duradry Recent Developments
7.9 Merz Ultherapy
7.9.1 Merz Ultherapy Profile
7.9.2 Merz Ultherapy Main Business
7.9.3 Merz Ultherapy Hyperhidrosis Treatment Products, Services and Solutions
7.9.4 Merz Ultherapy Hyperhidrosis Treatment Revenue (US$ Million) & (2020-2025)
7.9.5 Merz Ultherapy Recent Developments
7.10 Fotona
7.10.1 Fotona Profile
7.10.2 Fotona Main Business
7.10.3 Fotona Hyperhidrosis Treatment Products, Services and Solutions
7.10.4 Fotona Hyperhidrosis Treatment Revenue (US$ Million) & (2020-2025)
7.10.5 Fotona Recent Developments
7.11 BTXA
7.11.1 BTXA Profile
7.11.2 BTXA Main Business
7.11.3 BTXA Hyperhidrosis Treatment Products, Services and Solutions
7.11.4 BTXA Hyperhidrosis Treatment Revenue (US$ Million) & (2020-2025)
7.11.5 BTXA Recent Developments
7.12 Seaford Pharmaceuticals
7.12.1 Seaford Pharmaceuticals Profile
7.12.2 Seaford Pharmaceuticals Main Business
7.12.3 Seaford Pharmaceuticals Hyperhidrosis Treatment Products, Services and Solutions
7.12.4 Seaford Pharmaceuticals Hyperhidrosis Treatment Revenue (US$ Million) & (2020-2025)
7.12.5 Seaford Pharmaceuticals Recent Developments
7.13 Robugen GmbH
7.13.1 Robugen GmbH Profile
7.13.2 Robugen GmbH Main Business
7.13.3 Robugen GmbH Hyperhidrosis Treatment Products, Services and Solutions
7.13.4 Robugen GmbH Hyperhidrosis Treatment Revenue (US$ Million) & (2020-2025)
7.13.5 Robugen GmbH Recent Developments
8 Industry Chain Analysis
8.1 Hyperhidrosis Treatment Industrial Chain
8.2 Hyperhidrosis Treatment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Hyperhidrosis Treatment Sales Model
8.5.2 Sales Channel
8.5.3 Hyperhidrosis Treatment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Hyperhidrosis Treatment Market Trends
Table 2. Hyperhidrosis Treatment Market Drivers & Opportunity
Table 3. Hyperhidrosis Treatment Market Challenges
Table 4. Hyperhidrosis Treatment Market Restraints
Table 5. Global Hyperhidrosis Treatment Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Hyperhidrosis Treatment Revenue Market Share by Company (2020-2025)
Table 7. Key Companies Hyperhidrosis Treatment Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Hyperhidrosis Treatment Product Type
Table 9. Key Companies Time to Begin Mass Production of Hyperhidrosis Treatment
Table 10. Global Hyperhidrosis Treatment Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hyperhidrosis Treatment as of 2024)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Hyperhidrosis Treatment Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 14. Global Hyperhidrosis Treatment Sales Value by Type (2020-2025) & (US$ Million)
Table 15. Global Hyperhidrosis Treatment Sales Value by Type (2026-2031) & (US$ Million)
Table 16. Global Hyperhidrosis Treatment Sales Market Share in Value by Type (2020-2025)
Table 17. Global Hyperhidrosis Treatment Sales Market Share in Value by Type (2026-2031)
Table 18. Global Hyperhidrosis Treatment Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 19. Global Hyperhidrosis Treatment Sales Value by Application (2020-2025) & (US$ Million)
Table 20. Global Hyperhidrosis Treatment Sales Value by Application (2026-2031) & (US$ Million)
Table 21. Global Hyperhidrosis Treatment Sales Market Share in Value by Application (2020-2025)
Table 22. Global Hyperhidrosis Treatment Sales Market Share in Value by Application (2026-2031)
Table 23. Global Hyperhidrosis Treatment Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 24. Global Hyperhidrosis Treatment Sales Value by Region (2020-2025) & (US$ Million)
Table 25. Global Hyperhidrosis Treatment Sales Value by Region (2026-2031) & (US$ Million)
Table 26. Global Hyperhidrosis Treatment Sales Value by Region (2020-2025) & (%)
Table 27. Global Hyperhidrosis Treatment Sales Value by Region (2026-2031) & (%)
Table 28. Key Countries/Regions Hyperhidrosis Treatment Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 29. Key Countries/Regions Hyperhidrosis Treatment Sales Value, (2020-2025) & (US$ Million)
Table 30. Key Countries/Regions Hyperhidrosis Treatment Sales Value, (2026-2031) & (US$ Million)
Table 31. Allergan (AbbVie) Basic Information List
Table 32. Allergan (AbbVie) Description and Business Overview
Table 33. Allergan (AbbVie) Hyperhidrosis Treatment Products, Services and Solutions
Table 34. Revenue (US$ Million) in Hyperhidrosis Treatment Business of Allergan (AbbVie) (2020-2025)
Table 35. Allergan (AbbVie) Recent Developments
Table 36. GlaxoSmithKline Basic Information List
Table 37. GlaxoSmithKline Description and Business Overview
Table 38. GlaxoSmithKline Hyperhidrosis Treatment Products, Services and Solutions
Table 39. Revenue (US$ Million) in Hyperhidrosis Treatment Business of GlaxoSmithKline (2020-2025)
Table 40. GlaxoSmithKline Recent Developments
Table 41. Cynosure Basic Information List
Table 42. Cynosure Description and Business Overview
Table 43. Cynosure Hyperhidrosis Treatment Products, Services and Solutions
Table 44. Revenue (US$ Million) in Hyperhidrosis Treatment Business of Cynosure (2020-2025)
Table 45. Cynosure Recent Developments
Table 46. Journey Medical Corporation Basic Information List
Table 47. Journey Medical Corporation Description and Business Overview
Table 48. Journey Medical Corporation Hyperhidrosis Treatment Products, Services and Solutions
Table 49. Revenue (US$ Million) in Hyperhidrosis Treatment Business of Journey Medical Corporation (2020-2025)
Table 50. Journey Medical Corporation Recent Developments
Table 51. miraDry Basic Information List
Table 52. miraDry Description and Business Overview
Table 53. miraDry Hyperhidrosis Treatment Products, Services and Solutions
Table 54. Revenue (US$ Million) in Hyperhidrosis Treatment Business of miraDry (2020-2025)
Table 55. miraDry Recent Developments
Table 56. Alma Lasers Basic Information List
Table 57. Alma Lasers Description and Business Overview
Table 58. Alma Lasers Hyperhidrosis Treatment Products, Services and Solutions
Table 59. Revenue (US$ Million) in Hyperhidrosis Treatment Business of Alma Lasers (2020-2025)
Table 60. Alma Lasers Recent Developments
Table 61. Carpe Basic Information List
Table 62. Carpe Description and Business Overview
Table 63. Carpe Hyperhidrosis Treatment Products, Services and Solutions
Table 64. Revenue (US$ Million) in Hyperhidrosis Treatment Business of Carpe (2020-2025)
Table 65. Carpe Recent Developments
Table 66. Duradry Basic Information List
Table 67. Duradry Description and Business Overview
Table 68. Duradry Hyperhidrosis Treatment Products, Services and Solutions
Table 69. Revenue (US$ Million) in Hyperhidrosis Treatment Business of Duradry (2020-2025)
Table 70. Duradry Recent Developments
Table 71. Merz Ultherapy Basic Information List
Table 72. Merz Ultherapy Description and Business Overview
Table 73. Merz Ultherapy Hyperhidrosis Treatment Products, Services and Solutions
Table 74. Revenue (US$ Million) in Hyperhidrosis Treatment Business of Merz Ultherapy (2020-2025)
Table 75. Merz Ultherapy Recent Developments
Table 76. Fotona Basic Information List
Table 77. Fotona Description and Business Overview
Table 78. Fotona Hyperhidrosis Treatment Products, Services and Solutions
Table 79. Revenue (US$ Million) in Hyperhidrosis Treatment Business of Fotona (2020-2025)
Table 80. Fotona Recent Developments
Table 81. BTXA Basic Information List
Table 82. BTXA Description and Business Overview
Table 83. BTXA Hyperhidrosis Treatment Products, Services and Solutions
Table 84. Revenue (US$ Million) in Hyperhidrosis Treatment Business of BTXA (2020-2025)
Table 85. BTXA Recent Developments
Table 86. Seaford Pharmaceuticals Basic Information List
Table 87. Seaford Pharmaceuticals Description and Business Overview
Table 88. Seaford Pharmaceuticals Hyperhidrosis Treatment Products, Services and Solutions
Table 89. Revenue (US$ Million) in Hyperhidrosis Treatment Business of Seaford Pharmaceuticals (2020-2025)
Table 90. Seaford Pharmaceuticals Recent Developments
Table 91. Robugen GmbH Basic Information List
Table 92. Robugen GmbH Description and Business Overview
Table 93. Robugen GmbH Hyperhidrosis Treatment Products, Services and Solutions
Table 94. Revenue (US$ Million) in Hyperhidrosis Treatment Business of Robugen GmbH (2020-2025)
Table 95. Robugen GmbH Recent Developments
Table 96. Key Raw Materials Lists
Table 97. Raw Materials Key Suppliers Lists
Table 98. Hyperhidrosis Treatment Downstream Customers
Table 99. Hyperhidrosis Treatment Distributors List
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
Table 103. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Hyperhidrosis Treatment Product Picture
Figure 2. Global Hyperhidrosis Treatment Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Hyperhidrosis Treatment Sales Value (2020-2031) & (US$ Million)
Figure 4. Hyperhidrosis Treatment Report Years Considered
Figure 5. Global Hyperhidrosis Treatment Players Revenue Ranking (2024) & (US$ Million)
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Hyperhidrosis Treatment Revenue in 2024
Figure 7. Hyperhidrosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 8. Medications Picture
Figure 9. Surgical Treatments Picture
Figure 10. Physiotherapy Picture
Figure 11. Global Hyperhidrosis Treatment Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 12. Global Hyperhidrosis Treatment Sales Value Market Share by Type, 2024 & 2031
Figure 13. Product Picture of Primary Focal Hyperhidrosis
Figure 14. Product Picture of Secondary Generalized Hyperhidrosis
Figure 15. Global Hyperhidrosis Treatment Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 16. Global Hyperhidrosis Treatment Sales Value Market Share by Application, 2024 & 2031
Figure 17. North America Hyperhidrosis Treatment Sales Value (2020-2031) & (US$ Million)
Figure 18. North America Hyperhidrosis Treatment Sales Value by Country (%), 2024 VS 2031
Figure 19. Europe Hyperhidrosis Treatment Sales Value, (2020-2031) & (US$ Million)
Figure 20. Europe Hyperhidrosis Treatment Sales Value by Country (%), 2024 VS 2031
Figure 21. Asia Pacific Hyperhidrosis Treatment Sales Value, (2020-2031) & (US$ Million)
Figure 22. Asia Pacific Hyperhidrosis Treatment Sales Value by Region (%), 2024 VS 2031
Figure 23. South America Hyperhidrosis Treatment Sales Value, (2020-2031) & (US$ Million)
Figure 24. South America Hyperhidrosis Treatment Sales Value by Country (%), 2024 VS 2031
Figure 25. Middle East & Africa Hyperhidrosis Treatment Sales Value, (2020-2031) & (US$ Million)
Figure 26. Middle East & Africa Hyperhidrosis Treatment Sales Value by Country (%), 2024 VS 2031
Figure 27. Key Countries/Regions Hyperhidrosis Treatment Sales Value (%), (2020-2031)
Figure 28. United States Hyperhidrosis Treatment Sales Value, (2020-2031) & (US$ Million)
Figure 29. United States Hyperhidrosis Treatment Sales Value by Type (%), 2024 VS 2031
Figure 30. United States Hyperhidrosis Treatment Sales Value by Application (%), 2024 VS 2031
Figure 31. Europe Hyperhidrosis Treatment Sales Value, (2020-2031) & (US$ Million)
Figure 32. Europe Hyperhidrosis Treatment Sales Value by Type (%), 2024 VS 2031
Figure 33. Europe Hyperhidrosis Treatment Sales Value by Application (%), 2024 VS 2031
Figure 34. China Hyperhidrosis Treatment Sales Value, (2020-2031) & (US$ Million)
Figure 35. China Hyperhidrosis Treatment Sales Value by Type (%), 2024 VS 2031
Figure 36. China Hyperhidrosis Treatment Sales Value by Application (%), 2024 VS 2031
Figure 37. Japan Hyperhidrosis Treatment Sales Value, (2020-2031) & (US$ Million)
Figure 38. Japan Hyperhidrosis Treatment Sales Value by Type (%), 2024 VS 2031
Figure 39. Japan Hyperhidrosis Treatment Sales Value by Application (%), 2024 VS 2031
Figure 40. South Korea Hyperhidrosis Treatment Sales Value, (2020-2031) & (US$ Million)
Figure 41. South Korea Hyperhidrosis Treatment Sales Value by Type (%), 2024 VS 2031
Figure 42. South Korea Hyperhidrosis Treatment Sales Value by Application (%), 2024 VS 2031
Figure 43. Southeast Asia Hyperhidrosis Treatment Sales Value, (2020-2031) & (US$ Million)
Figure 44. Southeast Asia Hyperhidrosis Treatment Sales Value by Type (%), 2024 VS 2031
Figure 45. Southeast Asia Hyperhidrosis Treatment Sales Value by Application (%), 2024 VS 2031
Figure 46. India Hyperhidrosis Treatment Sales Value, (2020-2031) & (US$ Million)
Figure 47. India Hyperhidrosis Treatment Sales Value by Type (%), 2024 VS 2031
Figure 48. India Hyperhidrosis Treatment Sales Value by Application (%), 2024 VS 2031
Figure 49. Hyperhidrosis Treatment Industrial Chain
Figure 50. Hyperhidrosis Treatment Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
